C Dustin Waters

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Escherichia Coli

Randomized Controlled Trial

Candida Albicans

Top Venues

Open forum infectious diseases

Infection control and hospital epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Sameer Alzaidi, John J Veillette, Stephanie Shealy May, Jared Olson, Katarina Jackson, C Dustin Waters, Allison M Butler, Mary A Hutton, Whitney R Buckel, Brandon J Webb
Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source. Open forum infectious diseases 11 (2) (2023)
Sameer Alzaidi, John J Veillette, Stephanie Shealy May, Jared Olson, Katarina Jackson, C Dustin Waters, Allison M Butler, Mary A Hutton, Whitney R Buckel, Brandon J Webb
Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source. Open forum infectious diseases 11 (2) (2023)
Sameer Alzaidi, John J Veillette, Stephanie Shealy May, Jared Olson, Katarina Jackson, C Dustin Waters, Allison M Butler, Mary A Hutton, Whitney R Buckel, Brandon J Webb
Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source. Open forum infectious diseases 11 (2) (2023)
C Dustin Waters, Joshua Caraccio
Rate of positive cultures necessitating definitive treatment in patients receiving empiric vancomycin therapy. Infection control and hospital epidemiology 39 (8) (2018)